AVCN.TO
Avicanna Inc
Price:  
0.23 
CAD
Volume:  
318,726.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVCN.TO EV/EBITDA

-
Upside

As of 2025-11-19, the EV/EBITDA ratio of Avicanna Inc (AVCN.TO) is -26.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVCN.TO's latest enterprise value is 25.53 mil CAD. AVCN.TO's TTM EBITDA according to its financial statements is -0.95 mil CAD. Dividing these 2 quantities gives us the above AVCN.TO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
0.23 CAD
Stock Price
- CAD
Fair Price

AVCN.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-11-18 -29.35
2025-11-17 -26.94
2025-11-14 -30.56
2025-11-13 -32.36
2025-11-12 -31.16
2025-11-11 -29.95
2025-11-10 -31.16
2025-11-07 -30.56
2025-11-06 -30.56
2025-11-05 -30.56
2025-11-04 -29.35
2025-11-03 -32.36
2025-10-31 -32.36
2025-10-30 -31.16
2025-10-29 -31.76
2025-10-28 -32.36
2025-10-27 -31.16
2025-10-24 -32.36
2025-10-23 -31.76
2025-10-22 -32.36
2025-10-21 -29.95
2025-10-17 -32.36
2025-10-16 -33.57
2025-10-15 -35.38
2025-10-14 -32.36
2025-10-10 -31.76
2025-10-09 -32.36
2025-10-08 -31.16
2025-10-07 -32.97
2025-10-06 -32.36
2025-10-03 -30.56
2025-10-02 -29.95
2025-10-01 -29.95
2025-09-30 -29.35
2025-09-29 -29.95
2025-09-26 -30.56
2025-09-25 -29.95
2025-09-24 -29.95
2025-09-23 -29.95
2025-09-22 -30.56
2025-09-19 -30.56
2025-09-18 -30.56
2025-09-17 -29.95
2025-09-16 -29.95
2025-09-15 -32.36
2025-09-12 -32.36
2025-09-11 -32.97
2025-09-10 -32.36
2025-09-09 -32.97
2025-09-08 -32.36